CEO Update and US Investor Presentation
Bionomics Limited (ASX:BNO) today announced its CEO, Dr Deborah Rathjen, will present a company update at the Biotech Showcase 2011 in San Francisco, USA. The presentation highlights the progress of Bionomics' proprietary and partnered discovery and development pipeline including the BNC105 Phase II and BNC210 Phase I clinical programmes. The presentation will take place at 4.30pm in the Stockton Room, Parc 55 Wyndham, Union Square, San Francisco.
As part of activities surrounding the 29th JP Morgan Healthcare Conference, briefings will also be given to US institutional investors and pharmaceutical companies.
The presentation can be found on Bionomics' website www.bionomics.com.au.
Download this document
